The Global Medical Linear Accelerator Market is Growing at a CAGR of Over 7% During the Forecast Period 2019–2025
Speak directly to the analyst to clarify any post sales queries you may have.
The growing prevalence of cancer worldwide, coupled with rapid technological advancements and increased healthcare expenditure, is expected to boost the market growth. Linear accelerators (LINAC) are considered as breakthrough devices, which have revolutionized treatment due to their cost-effectiveness. Further, the market has witnessed a significant shift in cancer treatment delivery with increasing preference from invasive to non-invasive treatment procedures. As non-invasive treatment includes radiation therapy, which is the most advanced and cost-effective treatment option for patients. It helps to treat a wide range of cancers and could be used alone or in conjunction with surgery, chemotherapy, and other treatment procedures. Therefore, this phenomenal shift in consumer expectation has increased the acceptance of medical LINAC equipment.
The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.
The following factors are likely to contribute to the growth of the medical linear accelerator market during the forecast period:
- High Prevalence of Cancers
- Increasing Demand for Non-invasive Cancer Treatment
- Emergence of MRI-based Linear Accelerators
- High Popularity of Robotic-enabled Radiotherapy
The study considers the present scenario of the medical linear accelerator market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspects of the market. The report profiles and examines leading companies and other prominent companies operating in the market.
Medical Linear Accelerator Market: Segmentation
This research report includes detailed segmentation by product, application, end-user, and geography. The rapid use of radiotherapy with medical linear accelerator equipment for the treatment of breast cancer, along with the growing incidence of these cases, is responsible for the segment growth. With the increasing prevalence of breast cancers, the demand for advanced treatment options such as radiotherapy devices is expected to grow as they are highly targeted and effective in destroying the malignant cells.
Lung cancer treatment is projected to achieve maximum revenue owing to the rapid rise across the globe. Hence, the application of radiation therapy with LINAC for these treatments is likely to gain a lucrative share in the market. The increasing application of external beam radiation therapy (EBRT) is driving prominent vendors to offer advanced LINAC systems for lung cancer treatments.
The medical linear accelerator equipment segment is growing due to the growing incidence of cancers globally, coupled with the increasing demand for digitally advanced radiotherapy devices. The use of innovative oncology informatics platforms has led to rapid progress in radiation treatment planning, thereby saving time and cost. The demand for integration of digital solutions with LINAC is increasing as oncology informatics helps in better planning for radiotherapy and improves the effectiveness and patient outcomes in cancer care. The integration of informatics/software with radiation oncology is changing the treatment dynamics by providing end-users with smart and efficient tools to help receive, transmit, and store electronic information flawlessly.
The hospitals segment is likely to dominate the global medical linear accelerator market; however, the cancer care center segment is projected to grow at the highest CAGR during the forecast period. The adoption of advanced radiotherapy devices such as LINAC is high, as majority of patients prefer to visit hospitals for cancer treatment because they offer advanced radiotherapy infrastructure facilities.
Market Segmentation by Products
- Equipment
- Oncology Informatics/Software
Market Segmentation by Application
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Others
Market Segmentation by End-users
- Hospitals
- Cancer Care Centers
- Academic Institutes and Research Centers
Geographical Insights
North America is growing at a significant rate due to the growing preference for technologically advanced medical LINAC devices. The presence of a large pool of the patient population requiring radiotherapy, coupled with high acceptance of innovative devices and high awareness of non-invasive treatments, has collectively driven the North America market. Germany, France, the UK, Spain, and Italy are the major revenue contributors in Europe. The presence of highly sophisticated healthcare infrastructure, along with the high awareness of advanced oncology treatment, is increasing the demand for innovative radiotherapy devices. The APAC market is expected to witness the highest absolute growth during the forecast period.
Market Segmentation by Geography
- North America
- US
- Canada
- APAC
- Japan
- China
- South Korea
- Australia
- India
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- Turkey
- Saudi Arabia
- UAE
Key Vendor Analysis
The global market has only six vendors that provide medical linear accelerator equipment at the global and regional levels. The market is highly consolidated as the leading two vendors account for around 89% of the market share.
The market is witnessing rapid technological advancements and product launches. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers are continuously focusing on product development and offering advanced technology-enabled medical linear accelerator devices.
Key Vendors
- Varian Medical Systems
- Elekta
- Accuray
- Other Prominent Vendors
- SHINVA MEDICAL INSTRUMENT
- Panacea Medical Technologies
- ViewRay Technologies
Key Market Insights
- The report provides the following insights into the medical linear accelerator market for the forecast period 2020–2025.
- Offers sizing and growth prospects of the medical linear accelerator market for the forecast period 2020–2025.
- Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
- Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
- Delivers a complete overview of segments and the regional outlook of the market.
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.
Table of Contents
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Applications
4.4.3 Market Segmentation by End-users Type
4.4.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Cancer: An Overview
7.1.1 Background
7.1.2 Radiotherapy
7.2 Medical LINACs
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Growing Prevalence of Cancer
8.1.2 Technological Advances/Innovations
8.1.3 Increasing Demand for Non-Invasive Cancer Treatment
8.2 Market Growth Restraints
8.2.1 High Costs of LINACs
8.2.2 Lack of Infrastructure & Skilled Professionals
8.2.3 Alternate Treatment Options for Cancer
8.2.4 Risks and Complications Associated with RT
8.3 Market Opportunities and Trends
8.3.1 Product Approvals/Launches
8.3.2 Emergence of MRI-Based LINACs
8.3.3 Growing Popularity of Robotic Radiotherapy
8.3.4 Integration of AI in LINACs
9 Global Medical LINACs Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 By Product Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Equipment
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.4 Software
10.4.1 Market Overview
10.4.2 Market Size & Forecast
11 By Application
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Breast Cancer
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Prostate Cancer
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Lung Cancer
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 Head & Neck Cancer
11.6.1 Market Overview
11.6.2 Market Size & Forecast
11.7 Colorectal Cancer
11.7.1 Market Overview
11.7.2 Market Size & Forecast
11.8 Others
11.8.1 Market Overview
11.8.2 Market Size & Forecast
12 By End-Users
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Cancer Care Centers
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Academic Institutes & Research Centers
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 By Geography
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Market Size & Forecast
14.3.2 Canada: Market Size & Forecast
15 Europe
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 Germany: Market Size & Forecast
15.3.2 UK: Market Size & Forecast
15.3.3 Italy: Market Size & Forecast
15.3.4 France: Market Size & Forecast
15.3.5 Spain: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 China: Market Size & Forecast
16.3.2 Japan: Market Size & Forecast
16.3.3 India: Market Size & Forecast
16.3.4 Australia: Market Size & Forecast
16.3.5 South Korea: Market Size & Forecast
17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil: Market Size & Forecast
17.3.2 Mexico: Market Size & Forecast
17.3.3 Argentina: Market Size & Forecast
18 Middle East & Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey: Market Size & Forecast
18.3.2 Saudi Arabia: Market Size & Forecast
18.3.3 South Africa: Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis
19.2.1 Varian Medical Systems
19.2.2 Elekta
19.2.3 Accuray
19.2.4 VIEWRAY
19.2.5 SHINVA MEDICAL INSTRUMENT
19.2.6 Panacea Medical Technologies
20 Key Vendors
20.1 Varian Medical Systems
20.1.1 Business Overview
20.1.2 Major Product Offerings
20.1.3 Key Strengths
20.1.4 Key Strategies
20.1.5 Key Opportunities
20.2 Elekta
20.2.1 Business Overview
20.2.2 Major Product Offerings
20.2.3 Key Strengths
20.2.4 Key Strategies
20.2.5 Key Opportunities
20.3 Accuray
20.3.1 Business Overview
20.3.2 Major Product Offerings
20.3.3 Key Strengths
20.3.4 Key Strategies
20.3.5 Key Opportunities
21 Other Prominent Vendors
21.1 SHINVA MEDICAL INSTRUMENT
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.1.3 Key Strengths
21.1.4 Key Strategies
21.1.5 Key Opportunities
21.2 Panacea Medical Technologies
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.2.3 Key Strengths
21.2.4 Key Strategies
21.2.5 Key Opportunities
21.3 VIEWRAY TECHNOLOGIES
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.3.3 Key Strengths
21.3.4 Key Strategies
21.3.5 Key Opportunities
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 By Product
22.3.2 By Application
22.3.3 By End-users
22.3.4 By Geography
23 Appendix
23.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Medical LINACs Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of Growing Prevalence of Cancer
Exhibit 4 Global New Cancer Cases 2018 (% share)
Exhibit 5 Cancer Incidence: Segmentation by Geography 2018 (% share)
Exhibit 6 Impact of Technological Advance/Innovations
Exhibit 7 Impact of Increasing Demand for Non-Invasive Cancer Treatment
Exhibit 8 Cost Comparison of Various Cancer Treatments ($ thousands)
Exhibit 9 Global Market Opportunity for Medical LINACs
Exhibit 10 Impact of High Costs of LINACs
Exhibit 11 Impact of Lack of Infrastructure & Skilled Professionals
Exhibit 12 Distribution of Megavoltage Systems by Geography ($ share)
Exhibit 13 RT Units by Geography (per million population)
Exhibit 14 Alternate Treatment Options for Cancer
Exhibit 15 Common Side Effects 0f RT
Exhibit 16 Impact of Risks and Complications Associated with RT
Exhibit 17 Impact of Product Approvals/Launches
Exhibit 18 Impact of Emergence of MRI-based LINACs
Exhibit 19 Impact of Growing Popularity of Robotic Radiotherapy
Exhibit 20 Impact of Integration of AI in LINACs
Exhibit 21 Benefits of AI in LINACs
Exhibit 22 Global Medical LINACs Market: Opportunities Snapshot
Exhibit 23 Global Medical LINACs Market 2019−2025 ($ million)
Exhibit 24 Global Medical LINACs Market by Geography
Exhibit 25 Global Medical LINACs Market by Product Type
Exhibit 26 Global Medical LINACs Market by Application
Exhibit 27 Global Medical LINACs Market by End-users
Exhibit 28 Five Force Analysis 2019
Exhibit 29 Incremental Growth by Product Type 2019-2025
Exhibit 30 Global Medical LINACs Market by Product Type
Exhibit 31 Global Medical LINACs Market by Product: Incremental Growth
Exhibit 32 Global Medical LINAC Market by Product: Absolute Growth
Exhibit 33 Global Medical LINACs Market by Product 2019 & 2025 (%)
Exhibit 34 Global Medical LINACs Market by Product Type 2019−2025 ($ million)
Exhibit 35 Global Medical LINACs Market by Product Type 2019−2025 (% share)
Exhibit 36 Global Medical LINACs Market by Equipment: Absolute & Incremental Growth
Exhibit 37 Global New Cancer Cases 2018
Exhibit 38 Global Medical LINACs Equipment Market 2019−2025 ($ million)
Exhibit 39 Global Medical LINACs Market by Software: Absolute & Incremental Growth
Exhibit 40 Global Medical LINACs Software Market 2019−2025 ($ million)
Exhibit 41 Incremental Growth by Application 2019-2025
Exhibit 42 Global Medical LINACs Market by Applications
Exhibit 43 Global Medical LINACs Market by Applications: Incremental Growth
Exhibit 44 Global Medical LINACs Market by Applications: Absolute Growth
Exhibit 45 Global Medical LINACs Market by Applications 2019 & 2025 (% share)
Exhibit 46 Global Medical LINACs Market by Applications 2019−2025 ($ million)
Exhibit 47 Global Medical LINACs Market by Applications 2019−2025 (% share)
Exhibit 48 Medical LINACs Market by Breast Cancer: Absolute & Incremental Growth
Exhibit 49 Breast Cancer in Key Countries 2018 (Age Standardized Rate Per 100,000 Population)
Exhibit 50 Breast Cancer Incidence Rate: Geography 2018
Exhibit 51 Global Medical LINACs Market by Breast Cancer 2019−2025 ($ million)
Exhibit 52 Global Medical LINACs Market by Prostate Cancer: Absolute & Incremental Growth
Exhibit 53 Global Prostate Cancer: Age-standardized Rate per 100,000 Population 2018
Exhibit 54 Prostate Cancer Incidence: Segmentation by Geography 2018
Exhibit 55 Global Medical LINACs Market by Prostate Cancer 2019−2025 ($ million)
Exhibit 56 Global Medical LINACs Market by Lung Cancer: Absolute & Incremental Growth
Exhibit 57 Lung Cancer Incidence: Segmentation by Geography 2018
Exhibit 58 Global Medical LINACs Market by Lung Cancer 2019−2025 ($ million)
Exhibit 59 Global Medical LINACs by Head and Neck Cancer: Absolute & Incremental Growth
Exhibit 60 Global Medical LINAC Market by Head & Neck Cancer 2019−2025 ($ million)
Exhibit 61 Global Medical LINAC Accelerators Market by Colorectal Cancer: Absolute & Incremental Growth
Exhibit 62 Colorectal Cancer Incidence Rate by Geography 2018
Exhibit 63 Global Medical LINACs Market by Colorectal Cancer 2019−2025 ($ million)
Exhibit 64 Global Medical LINACs Market by Other Cancers: Absolute & Incremental Growth
Exhibit 65 Global Newly Diagnosed Cancer Cases 2018
Exhibit 66 Global Medical LINACs Market by Other Cancers 2019−2025 ($ million)
Exhibit 67 Incremental Growth by End-users 2019-2025
Exhibit 68 Global Medical LINACs Market by End-users
Exhibit 69 Global Medical LINACs Market by End-users: Absolute Growth
Exhibit 70 Global Medical LINAC Market by End-users: Incremental Growth
Exhibit 71 Global Medical LINAC Market by End-users 2019 & 2025 (% share)
Exhibit 72 Global Medical LINACs Market by End-users 2019−2025 ($ million)
Exhibit 73 Global Medical LINAC Market by End-Users 2019−2025 (% share)
Exhibit 74 Global Medical LINACs Market by Hospitals: Absolute & Incremental Growth
Exhibit 75 Global Medical LINACs Market by Hospitals 2019−2025 ($ million)
Exhibit 76 Global Medical LINACs Market by Cancer Care Centers: Absolute & Incremental Growth
Exhibit 77 Global Medical LINACs Market by Cancer Care Centers 2019−2025 ($ million)
Exhibit 78 Global Medical LINACs Market by Academic Institutes & Research Centers: Absolute & Incremental Growth
Exhibit 79 Global Medical LINACs Market by Academic Institutes & Research Centers 2019−2025 ($ million)
Exhibit 80 Incremental Growth by Geography 2019-2025
Exhibit 81 Global Medical LINACs Market by Geography
Exhibit 82 Global Medical LINACs Market by Geography 2019 ($ million)
Exhibit 83 Global Medical LINACs Market by Geography: Absolute Growth
Exhibit 84 Global Medical LINACs Market by Geography: Incremental Growth
Exhibit 85 Global Medical LINACs Market by Geography 2019 & 2025 (%)
Exhibit 86 Global Medical LINACs Market by Geography 2019−2025 ($ million)
Exhibit 87 Global Medical LINACs Market by Geography 2019−2025 (%)
Exhibit 88 Medical LINACs Market in North America: Key Countries 2019
Exhibit 89 Medical LINACs Market in North America: Absolute & Incremental Growth
Exhibit 90 New Cancer Cases in North America 2018
Exhibit 91 Medical LINACs Market in North America 2019−2025 ($ million)
Exhibit 92 Incremental Growth in North America 2019−2025
Exhibit 93 Number of New Cancer Cases in US 2018
Exhibit 94 Medical LINACs Market in US 2019−2025 ($ million)
Exhibit 95 New Cancer Cases in Canada 2018
Exhibit 96 Medical LINACs Market in Canada 2019−2025 ($ million)
Exhibit 97 Medical LINACs Market in Europe: Key Countries 2019
Exhibit 98 Europe Medical LINACs Market: Absolute & Incremental Growth
Exhibit 99 Number of New Cancer Cases in Europe 2018
Exhibit 100 Number of New Cancer Cases in Men in Europe 2018
Exhibit 101 Number of New Cancer Cases in Women in Europe 2018
Exhibit 102 Medical LINACs Market in Europe 2019–2025 ($ million)
Exhibit 103 Incremental Growth in Europe 2019-2025
Exhibit 104 Number of New Cancer Cases in Men & Women 2018
Exhibit 105 Medical LINACs Market in Germany 2019–2025 ($ million)
Exhibit 106 Number of New Cancer Cases in UK 2018
Exhibit 107 Medical LINACs Market in UK 2019–2025 ($ million)
Exhibit 108 Number of New Cancer Cases in Ital 2018
Exhibit 109 Medical LINACs Market in Italy 2019–2025 ($ million)
Exhibit 110 Number of New Cancer Cases in France 2018
Exhibit 111 Medical LINACs Market in France 2019–2025 ($ million)
Exhibit 112 Number of New Cancer Cases in Spain 2018
Exhibit 113 Medical LINACs Market in Spain 2019–2025 ($ million)
Exhibit 114 Medical LINACs Market in APAC: Key Countries 2019
Exhibit 115 Medical LINACs Market in APAC: Absolute & Incremental Growth
Exhibit 116 Number of New Cancer Cases in APAC 2018
Exhibit 117 Number of New Cancer Cases in APAC in Men 2018
Exhibit 118 Number of New Cancer Cases in APAC in Women 2018
Exhibit 119 Medical LINACs Market in APAC 2019–2025 ($ million)
Exhibit 120 Incremental Growth in APAC 2019-2025
Exhibit 121 New cancer Cases in China 218
Exhibit 122 Medical LINACs Market in China 2019–2025 ($ million)
Exhibit 123 New Cancer Cases in Japan 2018
Exhibit 124 Medical LINACs Market in Japan 2019–2025 ($ million)
Exhibit 125 Number of New Cancer Cases in India 2018
Exhibit 126 Medical LINACs Market in India 2019–2025 ($ million)
Exhibit 127 Number of New Cancer Cases in Australia 2018
Exhibit 128 Medical LINACs Market in Australia 2019–2025 ($ million)
Exhibit 129 Number of New Cancer Cases in Korea 2018
Exhibit 130 Medical LINACs Market in South Korea 2019–2025 ($ million)
Exhibit 131 Medical LINACs Market in Latin America: Key Countries 2019
Exhibit 132 Medical LINACs Market in Latin America: Absolute & Incremental Growth
Exhibit 133 Number of New Cancer Cases in Latin America 2018
Exhibit 134 Number of New Cancer Cases in Latin America in Men 2018
Exhibit 135 Number of New Cancer Cases in Latin America in Women 2018
Exhibit 136 Medical LINACs Market in Latin America 2019–2025 ($ million)
Exhibit 137 Incremental Growth in Latin America 2019-2025
Exhibit 138 Number of New Cancer cases in Brazil 2018
Exhibit 139 Medical LINACs Market in Brazil 2019–2025 ($ million)
Exhibit 140 Number of New Cancer Cases in Mexico 2018
Exhibit 141 Medical LINACs Market in Mexico 2019–2025 ($ million)
Exhibit 142 Number of New Cancer Cases in Argentina 2018
Exhibit 143 Medical LINACs Market in Argentina 2019–2025 ($ million)
Exhibit 144 Medical LINACs Market in MEA 2019
Exhibit 145 Medical LINACs Market in MEA: Absolute & Incremental Growth
Exhibit 146 Number of New Cancer Cases in Africa 2018
Exhibit 147 Medical LINACs Market in MEA 2019–2025 ($ million)
Exhibit 148 Incremental Growth in MEA 2019-2025
Exhibit 149 Number of New Cancer Cases in Turkey 2018
Exhibit 150 Medical LINACs Market in Turkey 2019–2025 ($ million)
Exhibit 151 Number of New Cancer Cases in Saudi Arabia 2018
Exhibit 152 Medical LINACs Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 153 Number of New Cancer Cases in South Africa 2018
Exhibit 154 Medical LINACs Market in South Africa 2019–2025 ($ million)
Exhibit 155 Global Medical LINACs Market: Key Vendors (% share)
Exhibit 156 Varian Medical Systems: R&D Expenditure 2016−2018 ($ million)
Exhibit 157 Varian Medical Systems: Revenue by Segments
Exhibit 158 Elekta: Revenue by Geography
Exhibit 159 Elekta: R&D Expenditure 2017−2019 ($ million)
Exhibit 160 Elekta: Revenue Breakdown by Geography
Exhibit 161 Accuray: Revenue Breakdown by Geography FY2019 (% share)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Technologically Advanced Medical LINACs by Key Players
Table 4 Approximate Cost of LINAC Systems
Table 5 Average Procedural Cost of Lung Cancer Radiotherapy with SBRT ($ thousands)
Table 6 Global Estimated Trends in Cancer Incidence 2010-2030
Table 7 Crude Cancer Incidence in LMICs
Table 8 Key Advantages of Other Available Treatment Options for Cancer
Table 9 Treatment Areas and Possible Side-effects of RT
Table 10 Recent Product Approvals and Launches in Global Medical LINACs Market
Table 11 Medical LINACs from Key Market Players
Table 12 LINAC Compatible Software by Key Market Players
Table 13 LINACs for Breast Cancer by Players
Table 14 Medical LINAC for Prostate Cancer by Players
Table 15 Medical LINACs for Lung Cancer by Players
Table 16 Medical LINACs for Head & Neck Cancer by Players
Table 17 Prominent Cancer Care Centers Around the World
Table 18 Prominent Academic Institutes & Research Centers
Table 19 CMS Approved New Rates in US 2018
Table 20 Estimated Number of LINACs in Key European Countries
Table 21 Global Medical LINACs Market: Top Vendors Ranking
Table 22 Varian Medical Systems: Key Product Offerings
Table 23 Elekta: Key Product Offerings
Table 24 Accuray: Key Product Offerings
Table 25 SHINVA MEDICAL INSTRUMENT: Key Product Offerings
Table 26 Panacea Medical Technologies: Key Product Offerings
Table 27 VIEWRAY TECHNOLOGIES: Key Product Offerings
Table 28 Global Medical LINACs Market by Products ($ million)
Table 29 Global Medical LINACs Market by Products (% share)
Table 30 Global Medical LINACs Market by Application ($ million)
Table 31 Global Medical LINACs Market by Applications (% share)
Table 32 Global Medical LINACs Market by End-users ($ million)
Table 33 Global Medical LINACs Market by End-users (% share)
Table 34 Global Medical LINACs Market by Geography ($ million)
Table 35 Global Medical LINACs Market by Geography (% share)"
Companies Mentioned
- Varian Medical Systems
- Elekta
- Accuray
- VIEWRAY
- SHINVA MEDICAL INSTRUMENT
- Panacea Medical Technologies
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
